Clinical study seeks to examine new combination therapy for treating AML patients

[News]

A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.

More... (http://www.news-medical.net/news/20170307/Clinical-study-seeks-to-examine-new-combination-therapy-for-treating-AML-patients.aspx)